openPR Logo
Press release

Diabetic Neuropathy Market Growth, Size, Share and Forecast 2019-2025

08-31-2020 11:16 AM CET | Health & Medicine

Press release from: Orion Market Research

Diabetic Neuropathy Market Growth, Size, Share and Forecast

The global diabetic neuropathy market is predicted to grow at a CAGR of over 6% during the forecast period. The factors driving the global diabetic neuropathy market include the rising prevalence of diabetes along with the neurological disorders among the peoples. Diabetic neuropathy is a common disorder for both types of diabetes patients that is type 1 as well as type 2. The main four disorders includes, autonomic neuropathy, affects the heart rate, digestion blood pressure along with other body functions.

A full report of Diabetic Neuropathy Market is available at: https://www.omrglobal.com/industry-reports/diabetic-neuropathy-market

The second one is peripheral neuropathy, which affects the nerves of the feet and legs, and causes loss of sensations in legs and hands. The third is proximal neuropathy, which directly affects thighs, legs, buttocks, and hips. Whereas, focal neuropathy affects the wrist, foot, thigh along with pain in the chest, back, and other body parts.

Rising geriatric population is also one of the key factors encouraging the growth of the global diabetic neuropathy market, as the older peoples are more prone to such diseases. According to WHO, the geriatric population is going to be double in 2050 as compared to 2000. In 2000, the global level proportion of the population over 65 years was 11% which is expected to be 22% by 2050. The geriatric population is expected to reach 2 billion by 2050 as compared to 605 million in 2010. Similarly, the number of geriatric populations over 80 years or older will be almost quadrupled to 395 million from 2000 to 2050.The rise in the geriatric population may also encourage the market during the forecast period.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/diabetic-neuropathy-market

Growing healthcare expenditures is another motivating factor for the growth of the global diabetic neuropathy industry. For instance, in the economies of Asia-Pacific, the healthcare systems are facing challenges such as the burden of increasing and aging population, delivery of adequate healthcare facilities to the masses, and low per capita income. The healthcare expenditure in these countries is growing significantly with the increasing interest from both the private and public sectors. Economies of the Asia-Pacific region (China and India) are amongst the fastest developing countries in the adoption and implementation of new technologies across the globe.

Further, the key players' contribution to the global diabetic neuropathy market growth is anticipated to be one of the major driving factors of the market. Abbott Laboratories, GlaxoSmithKline Plc, Lupin Ltd., Bioness Inc., and others are some of the key players operating the global diabetic neuropathy market. These key players are indulged in the rapid R&D activities regarding the development of novel and innovative treatment types of diabetic neuropathy during the forecast time frame.

Current Market Trends Covered in the Market Report:

• Increased investments by the government along with the private organizations concerning the early diagnosis and treatment of this severe disease is likely to positively affect the diabetic neuropathy market growth during the forecast period
• Peripheral neuropathy segment will account for significant growth in the diabetic neuropathy industry
• Novel product launches, rapid innovations along with the geographical expansion will be the key growth strategy adopted by the key players to sustain in the market.

Global Diabetic Neuropathy Market – Segmentation

By Treatment Type

• Medications
• Radiotherapy
• Physiotherapy
• Others

By Disorder Type

• Autonomic Neuropathy
• Peripheral Neuropathy
• Proximal Neuropathy
• Focal Neuropathy

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/diabetic-neuropathy-market

Global Diabetic Neuropathy Market – Segmentation by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Abbott Laboratories, Inc.
• Achelios Therapeutics Inc.
• Bioness, Inc.
• CuronzLtd.
• Depomed Inc.
• Eli Lilly and Co.
• GlaxoSmithKline Plc
• Glenmark Pharmaceuticals Ltd.
• Innovus Pharmaceuticals, Inc.
• Johnson & Johnson
• Lupin Ltd.
• NeuroMetrix, Inc.
• Nevro Corp.
• NovaDX
• Novartis International AG
• Pfizer Inc.
• RxFunction, Inc.
• Stimwave Technologies Inc.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Neuropathy Market Growth, Size, Share and Forecast 2019-2025 here

News-ID: 2124754 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Neuropathy

07-14-2025 | Health & Medicine
Getnews
Neuropathy Care Centers Launches National Push to Rethink Peripheral Neuropathy …
A healthcare organization builds out a collaborative model aimed at earlier intervention and improved patient understanding WHEATON, IL - July 14, 2025 - Neuropathy Care Centers, a Wheaton-based healthcare organization, today announced the expansion of its national initiative to improve how Peripheral Neuropathy is identified and managed across the U.S. The organization is developing a growing network of providers focused on early detection and conservative, nerve-focused care, an effort intended to
Chemotherapy Induced Peripheral Neuropathy Market Trends and Insights, Toward Sa …
Overview of the Market Chemotherapy Induced Peripheral Neuropathy (CIPN) is one of the most common and debilitating side effects of cancer treatment, affecting a significant portion of chemotherapy patients. CIPN occurs when chemotherapy drugs cause damage to the peripheral nerves, leading to symptoms such as numbness, tingling, burning sensations, and pain, primarily in the hands and feet. With the growing global prevalence of cancer, the incidence of CIPN is also rising,
Prominent Diabetic Peripheral Neuropathy Market Trend for 2025: Advancements In …
What industry-specific factors are fueling the growth of the diabetic peripheral neuropathy market? The increase in obesity-related health issues is expected to drive the growth of the diabetic peripheral neuropathy (DPN) market. Obesity, characterized by excessive body fat accumulation, significantly increases the risk of chronic diseases, including type 2 diabetes. This, in turn, heightens the occurrence of diabetic peripheral neuropathy, a complication where high blood sugar levels cause nerve damage. The
Major Market Shift in Peripheral Neuropathy Industry: Technological Advancements …
What Is the Forecasted Market Size and Growth Rate for the Peripheral Neuropathy Market? The size of the peripheral neuropathy market has seen a rapid expansion in recent years, set to increase from $4.09 billion in 2024 to $4.62 billion in 2025, representing a compound annual growth rate (CAGR) of 13.2%. This growth during the historical period is due to a variety of factors including the rising prevalence of chronic illnesses
Combatting Peripheral Neuropathy: Breakthroughs and Beyond
The Business Research Company recently released a comprehensive report on the Global Peripheral Neuropathy Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, the peripheral neuropathy market
Multifocal Motor Neuropathy Market - Progress in nerve restoration: Driving adva …
Newark, New Castle, USA: The "Multifocal Motor Neuropathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Multifocal Motor Neuropathy Market: https://www.growthplusreports.com/report/multifocal-motor-neuropathy-market/8810 This latest report researches the industry structure,